(Q36246359)

English

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Y Ravindranath

1

1 reference

Europe PubMed Central

13 August 2017

M Chang

2

1 reference

Europe PubMed Central

13 August 2017

C P Steuber

3

1 reference

Europe PubMed Central

13 August 2017

D Becton

4

1 reference

Europe PubMed Central

13 August 2017

G Dahl

5

1 reference

Europe PubMed Central

13 August 2017

C Civin

6

1 reference

Europe PubMed Central

13 August 2017

B Camitta

7

1 reference

Europe PubMed Central

13 August 2017

A Carroll

8

1 reference

Europe PubMed Central

13 August 2017

S C Raimondi

9

1 reference

Europe PubMed Central

13 August 2017

H J Weinstein

10

1 reference

Europe PubMed Central

13 August 2017

Pediatric Oncology Group

11

1 reference

Europe PubMed Central

13 August 2017

publication date

1 December 2005

1 reference

Europe PubMed Central

13 August 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

13 August 2017

19

1 reference

Europe PubMed Central

13 August 2017

12

1 reference

Europe PubMed Central

13 August 2017

2101-2116

1 reference

Europe PubMed Central

13 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403927

0 references

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Down syndrome, drug metabolism and chromosome 21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Effect of altering conditions of the sequence method on baroreflex sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Down syndrome and acute myeloid leukemia: the paradox of increased risk for leukemia and heightened sensitivity to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy for childhood acute myeloid leukemia: role of allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Who should be transplanted for AML?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403927

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36246359&oldid=2004433053"